Selectra J. Lamarck Biotech Class A Fonds 12224066 / LU0574993464
429.74
EUR
2.80
EUR
0.66
%
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Dokumente | Sharpe Ratio | |
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Anlageziel Selectra J. Lamarck Biotech Class A Fonds
The main objective of this sub-fund is to profit from increasing share prices in the biotechnology sector. The focus is on mature top tier pharmaceutical biotech companies and companies with interesting pipeline of products in development in a single or numerous markets, like Nasdaq or NYSE. The followed investment policy will enable the Sub-Fund to increase overall return relative to the Nasdaq Biotech Index by active stock selection of companies, offering the most promising technology platform.
Stammdaten
| Valor | 12224066 |
| ISIN | LU0574993464 |
| Fondsgesellschaft | J. Lamarck Asset Management |
| Kategorie | Branchen: Biotechnologie |
| Währung | EUR |
| Mindestanlage | 934’892.96 |
| VL-fähig? | Nein |
| Thesaurierend/Ausschüttend | Thesaurierend |
| Fondsmanager | - |
Aktuelle Daten
| Fondsnote | - |
| Aktueller Rücknahmepreis | 429.74 |
| Fondsvolumen | 70’794’000.66EUR |
| Total Expense Ratio (TER) | 1.30% |
Gebühren
| Verwaltungsgebühr | - |
| Depotbankgebühr | 0.05 % |
| Rücknahmegebühr | 0.00 % |
| Ausgabeaufschlag | 3.00 % |
Basisdaten
| Auflagedatum | 10.01.2011 |
| Depotbank | Quintet Private Bank (Europe) S.A. |
| Zahlstelle | Quintet Private Bank (Europe) S.A. |
| Domizil | Luxembourg |
| Geschäftsjahr | 31.12.2025 |
Performancedaten
| Veränderung Vortag | 2.80 EUR (0.66 %) |